Recent Clinical Treatment and Basic Research on the Alveolar Bone.

Area of Science:

• Periodontology and Regenerative Medicine
• Biomaterials and Dental Implantology

Background:

• Periodontal diseases lead to alveolar bone resorption, compromising tooth support.
• Traditional treatments focus on halting disease progression, with limited regenerative capacity.
• Alveolar bone loss often results in irreversible changes, impacting dental aesthetics and function.

Purpose of the Study:

• To review current understanding of alveolar bone biology and its role in periodontal disease.
• To explore advancements in regenerative therapies for periodontal tissues.
• To discuss the potential of induced pluripotent stem cell (iPS) technology in periodontitis treatment.

Main Methods:

• Review of clinical practices and techniques in periodontal disease management.
• Analysis of scientific evidence supporting bone augmentation methods.
• Exploration of recent basic research in periodontal tissue regeneration, including iPS cell applications.

Main Results:

• Periodontal disease causes significant and often permanent alveolar bone loss.
• Regenerative treatments are emerging as viable options for restoring periodontal tissues.
• iPS cell technology shows promise for regenerating alveolar bone and periodontal ligament.

Conclusions:

• Significant advancements in materials science and regenerative medicine are improving periodontal treatment outcomes.
• iPS cell technology represents a promising frontier for treating periodontitis and associated alveolar bone defects.
• Future research directions include refining iPS cell-based therapies for clinical application in periodontology.